DNTH Dianthus Therapeutics, Inc. - Common Stock
$115.97
价格 · 八月 19, 2026
截至...的财报数据 八月 4, 2026
52周区间
$21–$118
98% of range
分析师评级
BUY
22 analysts
目标价
$138
+19% upside
P/E (TTM)
-27.6
ROE
-40.8%
净利润率
-7973.3%
关于 Dianthus Therapeutics, Inc. - Common Stock 公司概况(来自维基百科)
DNTH 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$115.97
市值
$5.01B
P/E (TTM)
-27.6
每股收益 (TTM)
$-4.20
营收 (TTM)
$2M
股息收益率
—
ROE
-40.8%
负债/权益
—
52周区间
$21 – $118
DNTH 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$2M
2016-12-31
→
2025-12-31
EPS
$-4.20
2020-12-31
→
2025-12-31
自由现金流
—
2018-12-31
→
2021-12-31
利润率
-7973.3%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
指标
5年趋势
DNTH
同行中位数
P/E (TTM)
-27.6
37.2
P/S (TTM) (市销率 (TTM))
2462.0
9.9
P/B (市净率)
10.2
8.3
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
DNTH
同行中位数
Operating Margin (营业利润率)
-8739.3%
—
Net Profit Margin (净利润率)
-7973.3%
-15.1%
ROA
-35.9%
-23.3%
ROE
-40.8%
-30.6%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
DNTH
同行中位数
Current Ratio (流动比率)
13.3
6.3
Quick Ratio (速动比率)
13.2
—
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
DNTH
同行中位数
Revenue YoY (营收同比增长)
-67.3%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
DNTH
同行中位数
DNTH 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
22 位分析师
- 强烈买入 10 45.5%
- 买入 11 50.0%
- 持有 1 4.5%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
13 位分析师 · 2026-08-15
中位数
$132.00
现在
$115.97
最低
$109.00
最高
$200.00
中位数目标
$132.00
+13.8%
平均目标
$137.62
+18.7%
收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
平均惊喜
-0.02%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.90 | $-0.87 | -0.03% |
| 2026年3月31日 | $-0.85 | $-1.09 | 0.24% |
| 2025年12月31日 | $-1.43 | $-1.10 | -0.33% |
| 2025年9月30日 | $-0.97 | $-0.88 | -0.09% |
| 2025年6月30日 | $-0.88 | $-0.89 | 0.01% |
| 2025年3月31日 | $-0.82 | $-0.87 | 0.05% |
同行比较(GICS 子行业) 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| SRRK | $4.78B | -13.4 | — | — | -157.9% | — |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | — |
| COGT | $5.72B | -16.4 | — | — | -83.1% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
| DYN | $3.23B | -5.6 | — | — | -57.8% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $6M | $3M | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $146M | $83M | $33M | $29M | $47M | $51M | $59M | $41M | $28M | |
| SG&A Expense | $34M | $25M | $18M | $7M | $28M | $28M | $24M | $19M | $8M | |
| Operating Expenses | $180M | $108M | $51M | $36M | $75M | $79M | $83M | $60M | $36M | |
| Operating Income | $-178M | $-102M | $-48M | $-30M | $-75M | $-79M | $-83M | $-60M | $-36M | |
| Interest Income | $16M | $17M | $5M | · | · | · | · | · | · | |
| Other Non-op | $-974.0K | $-554.0K | $-60.0K | $-52.0K | · | · | · | $2M | $236.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-162M | $-85M | $-44M | $-28M | $-71M | $-75M | $-77M | $-58M | $-35M | |
| EPS (Basic) | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 | $-1.71 | · | · | · | |
| EPS (Diluted) | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 | $-1.71 | · | · | · | |
| Shares (Basic) | 38,617,580 | 33,313,849 | 5,153,423 | 874,234 | 54,948,808 | 43,920,121 | · | · | · | |
| Shares (Diluted) | 38,617,580 | 33,313,849 | 5,153,423 | 874,234 | 54,948,808 | 43,920,121 | · | · | · | |
| EBITDA | $-178M | $-102M | $-48M | · | $-73M | $-77M | $-81M | $-59M | · |
资产负债表 22
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $23M | $132M | $15M | $132M | $58M | $65M | $58M | $51M | |
| Short-term Investments | $353M | $252M | $41M | $60M | $45M | $91M | $81M | $84M | · | |
| Receivables | $52.0K | $0 | $294.0K | $5M | · | · | · | · | · | |
| Prepaid Expense | $5M | $5M | $3M | $905.0K | $4M | $3M | $4M | $3M | $936.0K | |
| Other Current Assets | $86.0K | $355.0K | $0 | · | · | · | · | · | · | |
| Current Assets | $409M | $281M | $177M | $82M | $181M | $152M | $150M | $145M | $53M | |
| PP&E (Net) | $296.0K | $194.0K | $185.0K | $142.0K | $7M | $8M | $10M | $10M | $2M | |
| PP&E (Gross) | $600.0K | $387.0K | $282.0K | $172.0K | $14M | $13M | $13M | $11M | $2M | |
| Accum. Depreciation | $304.0K | $193.0K | $97.0K | $30.0K | $7M | $5M | $3M | $1M | $382.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | $4.0K | |
| Total Assets | $531M | $374M | $179M | $83M | $190M | $162M | $162M | $157M | $54M | |
| Accounts Payable | $10M | $5M | $3M | $1M | $3M | $4M | $3M | $3M | $167.0K | |
| Accrued Liabilities | $19M | $13M | $7M | $7M | $8M | $8M | $11M | $7M | $4M | |
| Current Liabilities | $31M | $18M | $10M | $8M | $11M | $11M | $14M | $10M | $4M | |
| Capital Leases | $1M | $1M | $168.0K | $438.0K | $0 | · | · | · | · | |
| Total Liabilities | $38M | $22M | $11M | $9M | $17M | $18M | $20M | $12M | $4M | |
| Common Stock | $43.0K | $31.0K | $15.0K | $0 | $59.0K | $49.0K | $39.0K | $33.0K | $2.0K | |
| Retained Earnings | $-337M | $-174M | $-89M | $-46M | $-326M | $-254M | $-179M | $-103M | $-45M | |
| AOCI | $489.0K | $106.0K | $47.0K | $-161.0K | $-30.0K | $-23.0K | $8.0K | $-8.0K | · | |
| Stockholders' Equity | $493M | $352M | $169M | $-44M | $-17M | $144M | $141M | $146M | $-42M | |
| Liabilities + Equity | $531M | $374M | $179M | $83M | $190M | $162M | $162M | $157M | $54M | |
| Shares Outstanding | 43,223,090 | 31,115,341 | 14,817,696 | 875,279 | 58,799,157 | 48,533,135 | 39,260,532 | 33,305,033 | 2,351,247 |
现金流 12
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $2M | $2M | $2M | $2M | $875.0K | $376.0K | |
| Stock-based Comp | $23M | $13M | $3M | $2M | $10M | $10M | $10M | $11M | $2M | |
| Other Non-cash | · | · | · | · | $-723.0K | $-1M | $8M | $4M | · | |
| Operating Cash Flow | $-129M | $-78M | $-37M | $-29M | $-60M | $-64M | $-57M | $-42M | $-22M | |
| CapEx | · | · | · | $314.0K | $1M | $400.0K | $3M | $8M | $2M | |
| Investing Cash Flow | $-123M | $-287M | $20M | $-60M | $43M | $-11M | $2M | $-92M | $-2M | |
| Stock Issued | $317.0K | $0 | $0 | $3M | $0 | $65M | $61M | $93M | · | |
| Net Stock Activity | $317.0K | $39M | · | · | · | $65M | $61M | · | · | |
| Financing Cash Flow | $280M | $256M | $134M | $97M | $90M | $68M | $62M | $142M | $71M | |
| Net Change in Cash | $28M | $-109M | $117M | $8M | $73M | $-7M | $7M | $9M | $47M | |
| Taxes Paid | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | $-61M | $-64M | $-60M | $-50M | · |
盈利能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -8739.3% | -1633.7% | · | · | · | · | · | · | · | |
| Net Margin | -7973.3% | -1362.8% | · | · | · | · | · | · | · | |
| EBITDA Margin | -8739.3% | -1633.7% | · | · | · | · | · | · | · | |
| ROA | -35.9% | -30.7% | -33.2% | · | -40.5% | -46.4% | -48.2% | -54.3% | · | |
| ROE | -40.8% | -24.6% | -25.1% | · | -39.3% | -49.5% | -50.7% | -37.7% | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.3 | 15.2 | 18.4 | · | 16.6 | 13.3 | 10.6 | 13.9 | · | |
| Quick Ratio | 13.2 | 15.0 | 18.1 | · | 16.3 | 13.0 | 10.3 | 13.7 | · |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | 0.0 | 0.0 | · | |
| Receivables Turnover | 78.3 | 11.3 | · | · | · | · | · | · | · |
增长率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -67.3% | 120.6% | · | · | · | · | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $6M | $3M | · | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-162M | $-85M | $-44M | $-28M | $-71M | $-75M | $-77M | $-58M | · | |
| Market Cap | $1.78B | $678M | $154M | · | $4.17B | $6.09B | $9.52B | $3.04B | · | |
| P/E | -9.8 | -8.5 | -1.2 | -0.2 | -54.9 | -73.4 | · | · | · | |
| P/S | 874.9 | 108.8 | 54.5 | · | · | · | · | · | · | |
| P/B | 3.6 | 1.9 | 0.9 | · | 24.1 | 42.3 | 67.4 | 20.9 | · | |
| P / Tangible Book | 3.6 | 1.9 | 0.9 | · | · | 42.3 | · | · | · | |
| P / Cash Flow | -13.8 | -8.7 | -4.2 | · | -70.0 | -95.1 | -166.8 | -72.5 | · | |
| P / FCF | · | · | · | · | -68.6 | -94.5 | -158.3 | -61.3 | · | |
| Earnings Yield | -10.2% | -11.7% | -81.2% | -508.9% | -1.8% | -1.4% | · | · | · |
损益表 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $284.0K | $396.0K | $193.0K | $1M | $1M | $2M | $2M | $874.0K | $457.0K | $924.0K | · | · | · | $1M | |
| R&D Expense | $49M | $35M | $60M | $32M | $26M | $27M | $26M | $26M | $18M | $13M | $9M | $8M | $10M | $6M | $-6M | $7M | |
| SG&A Expense | $14M | $12M | $10M | $8M | $9M | $7M | $7M | $7M | $6M | $6M | $5M | $9M | $2M | $2M | $-9M | $2M | |
| Operating Expenses | $62M | $47M | $70M | $41M | $35M | $34M | $33M | $32M | $24M | $19M | $13M | $17M | $13M | $8M | $-15M | $9M | |
| Operating Income | $-61M | $-47M | $-70M | $-40M | $-35M | $-33M | $-32M | $-30M | $-22M | $-18M | $-13M | $-16M | $-12M | $-8M | $20M | $-8M | |
| Interest Income | $12M | $6M | $11M | $1M | $3M | $4M | $7M | $2M | $4M | $4M | · | · | · | · | · | · | |
| Other Non-op | $-370.0K | $-249.0K | $-409.0K | $-360.0K | $-107.0K | $-98.0K | $-382.0K | $22.0K | $-80.0K | $-114.0K | $-19.0K | $-15.0K | $-23.0K | $-3.0K | $-43.0K | $-2.0K | |
| Net Income | $-50M | $-41M | $-64M | $-37M | $-32M | $-30M | $-28M | $-25M | $-18M | $-14M | $-11M | $-15M | $-11M | $-7M | $-10M | $-8M | |
| EPS (Basic) | $-0.90 | $-0.85 | $-1.53 | $-0.97 | $-0.88 | $-0.82 | $-0.76 | $-0.74 | $-0.51 | $-0.54 | $16.16 | $-3.78 | $-12.73 | $-8.10 | $-22.99 | $-8.90 | |
| EPS (Diluted) | $-0.90 | $-0.85 | $-1.53 | $-0.97 | $-0.88 | $-0.82 | $-0.76 | $-0.74 | $-0.51 | $-0.54 | $16.16 | $-3.78 | $-12.73 | $-8.10 | $-22.99 | $-8.90 | |
| Shares (Basic) | 56,029,124 | 48,032,742 | -70,789,516 | 37,794,088 | 35,822,308 | 35,790,700 | -60,815,392 | 34,236,728 | 34,227,038 | 25,665,475 | -503,072 | 3,906,886 | 874,900 | 874,709 | -117,614,793 | 874,327 | |
| Shares (Diluted) | 56,029,124 | 48,032,742 | -70,789,516 | 37,794,088 | 35,822,308 | 35,790,700 | -60,815,392 | 34,236,728 | 34,227,038 | 25,665,475 | -503,072 | 3,906,886 | 874,900 | 874,709 | -117,614,793 | 874,327 | |
| EBITDA | $-61M | $-47M | · | $-40M | $-35M | $-33M | · | $-30M | $-22M | $-18M | · | $-16M | $-7M | $-32M | · | $-17M |
资产负债表 21
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $628M | $51M | $56M | $13M | $10M | $23M | $34M | $314M | $330M | $132M | $157M | $63M | $49M | $15M | $59M | |
| Short-term Investments | $776M | $484M | $353M | $347M | $244M | $253M | $252M | $247M | $47M | $47M | $41M | $33M | · | · | $60M | $69M | |
| Receivables | $106.0K | $1M | $52.0K | $5M | $39.0K | $1M | $0 | $1M | $840.0K | $435.0K | $294.0K | $232.0K | · | · | $5M | · | |
| Prepaid Expense | $11M | $7M | $5M | $6M | $6M | $7M | $5M | $4M | $3M | $3M | $3M | $832.0K | $1M | $3M | $905.0K | $4M | |
| Other Current Assets | $184.0K | $83.0K | $86.0K | $73.0K | $111.0K | $392.0K | $355.0K | · | · | · | $0 | · | · | · | · | · | |
| Current Assets | $898M | $1.12B | $409M | $414M | $264M | $271M | $281M | $287M | $366M | $381M | $177M | $191M | $79M | $83M | $82M | $132M | |
| PP&E (Net) | $418.0K | $274.0K | $296.0K | $185.0K | $207.0K | $191.0K | $194.0K | $189.0K | $189.0K | $195.0K | $185.0K | $195.0K | $0 | $0 | $142.0K | $6M | |
| PP&E (Gross) | $791.0K | $610.0K | $600.0K | $462.0K | $457.0K | $411.0K | $387.0K | $356.0K | $331.0K | $314.0K | $282.0K | $272.0K | · | · | $172.0K | · | |
| Accum. Depreciation | $373.0K | $336.0K | $304.0K | $277.0K | $250.0K | $220.0K | $193.0K | $167.0K | $142.0K | $119.0K | $97.0K | $77.0K | · | · | $30.0K | · | |
| Total Assets | $1.21B | $1.25B | $531M | $577M | $326M | $349M | $374M | $354M | $369M | $382M | $179M | $192M | $79M | $83M | $83M | $164M | |
| Accounts Payable | $6M | $5M | $10M | $7M | $5M | $8M | $5M | $8M | $4M | $3M | $3M | $1M | $813.0K | $1M | $1M | $3M | |
| Accrued Liabilities | $26M | $31M | $19M | $16M | $14M | $8M | $13M | $8M | $6M | $6M | $7M | $11M | · | · | $7M | $7M | |
| Current Liabilities | $34M | $38M | $31M | $24M | $20M | $17M | $18M | $16M | $10M | $9M | $10M | $13M | $4M | $6M | $8M | $13M | |
| Capital Leases | $913.0K | $965.0K | $1M | $1M | $1M | $1M | $1M | $0 | $30.0K | $97.0K | $168.0K | $257.0K | $0 | $0 | $438.0K | $27M | |
| Total Liabilities | $41M | $46M | $38M | $31M | $23M | $20M | $22M | $16M | $11M | $10M | $11M | $14M | $4M | $6M | $9M | $40M | |
| Common Stock | $55.0K | $54.0K | $43.0K | $43.0K | $32.0K | $32.0K | $31.0K | $29.0K | $29.0K | $29.0K | $15.0K | $15.0K | $61.0K | $61.0K | $0 | $61.0K | |
| Retained Earnings | $-428M | $-378M | $-337M | $-272M | $-236M | $-204M | $-174M | $-146M | $-121M | $-103M | $-89M | $-79M | $-434M | $-431M | $-46M | $-382M | |
| AOCI | $-2M | $-575.0K | $489.0K | $163.0K | $98.0K | $270.0K | $106.0K | $681.0K | $-37.0K | $-27.0K | $47.0K | $-4.0K | $-3.0K | $-16.0K | $-161.0K | $-462.0K | |
| Stockholders' Equity | $1.17B | $1.20B | $493M | $546M | $303M | $329M | $352M | $338M | $358M | $373M | $169M | $178M | $75M | $77M | $-44M | $124M | |
| Liabilities + Equity | $1.21B | $1.25B | $531M | $577M | $326M | $349M | $374M | $354M | $369M | $382M | $179M | $192M | $79M | $83M | $83M | $164M | |
| Shares Outstanding | 54,798,338 | 54,582,749 | 43,223,090 | 42,854,563 | 32,176,482 | 32,125,933 | 31,115,341 | 29,366,352 | 29,352,140 | 29,348,626 | 14,817,696 | 14,817,762 | 60,652,197 | 60,648,821 | 875,279 | 60,555,520 |
现金流 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $421.0K | · | $471.0K | |
| Stock-based Comp | $12M | $11M | $6M | $6M | $6M | $5M | $4M | $4M | $3M | $2M | $726.0K | $1M | $489.0K | $533.0K | $513.0K | $-3M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | $2M | $18M | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-7M | · | · | |
| Operating Cash Flow | $-49M | $-29M | $-47M | $-31M | $-24M | $-28M | $-27M | $-21M | $-15M | $-15M | $-12M | $17M | $21M | $-10M | $-9M | $16M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $245.0K | · | $158.0K | |
| Investing Cash Flow | $-479M | $-134M | $37M | $-201M | $26M | $15M | $-23M | $-259M | $1M | $-6M | $-8M | $-17M | $13M | $18M | $-13M | $-7M | |
| Stock Issued | $0 | $120.0K | $1.0K | $187.0K | $0 | $129.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | $120.0K | · | · | · | $129.0K | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $10M | $739M | $5M | $275M | $568.0K | $161.0K | $40M | $296.0K | $-2M | $218M | $-5M | $138M | $0 | $0 | $0 | $97M | |
| Net Change in Cash | $-517M | $577M | $-5M | $43M | $3M | $-13M | $-11M | $-280M | $-16M | $197M | $-25M | $139M | $34M | $8M | $-22M | $106M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-36M | · | · |
盈利能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -10173.7% | -18096.9% | -2852.7% | · | · | · | · | · | -1705.5% | · | · | · | · | |
| Net Margin | · | · | · | -9284.1% | -16388.1% | -2537.5% | · | · | · | · | · | -1597.7% | · | · | · | · | |
| EBITDA Margin | · | · | · | -10173.7% | -18096.9% | -2852.7% | · | · | · | · | · | -1705.5% | · | · | · | · | |
| ROA | -6.5% | -5.1% | · | -7.9% | -9.1% | -8.1% | · | -9.2% | -7.9% | -5.9% | · | -8.3% | -2.6% | -21.0% | · | -8.7% | |
| ROE | -6.8% | -5.3% | · | -8.3% | -9.6% | -8.4% | · | -9.8% | -8.1% | -6.1% | · | -9.8% | -3.1% | -25.5% | · | -10.2% |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.1 | 29.3 | · | 17.3 | 13.1 | 16.0 | · | 18.3 | 36.5 | 42.5 | · | 14.6 | 19.5 | 13.9 | · | 10.2 | |
| Quick Ratio | 25.8 | 29.1 | · | 17.1 | 12.8 | 15.6 | · | 18.0 | 36.1 | 42.1 | · | 14.5 | 15.5 | 8.1 | · | 9.9 |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | 0.0 | · | · | · | · | |
| Receivables Turnover | · | · | · | 0.1 | 0.4 | 1.6 | · | · | · | · | · | 8.0 | · | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $4M | · | $4M | $5M | $6M | · | $6M | · | · | · | · | · | · | · | · | |
| Net Income TTM | $-159M | $-139M | · | $-123M | $-104M | $-86M | · | $-71M | $-57M | $-47M | · | $-41M | $-32M | $-25M | · | $-36M | |
| Market Cap | $5.34B | $4.58B | · | $1.69B | $599M | $583M | · | $804M | $760M | $880M | · | $203M | $738M | $767M | · | $1.37B | |
| P/E | -27.1 | -23.8 | · | -11.5 | -6.3 | -7.0 | · | -4.9 | -1.5 | -1.2 | · | -0.4 | -0.4 | -0.7 | · | -2.3 | |
| P/S | 1361.3 | 1167.3 | · | 429.7 | 111.2 | 96.0 | · | 137.8 | · | · | · | · | · | · | · | · | |
| P/B | 4.6 | 3.8 | · | 3.1 | 2.0 | 1.8 | · | 2.4 | 2.1 | 2.4 | · | 1.1 | 9.9 | 9.9 | · | 11.0 | |
| P / Tangible Book | 4.6 | 3.8 | · | 3.1 | 2.0 | 1.8 | · | 2.4 | 2.1 | 2.4 | · | 1.1 | 9.9 | 9.9 | · | 11.0 | |
| P / Cash Flow | · | -158.7 | · | · | · | -21.1 | · | · | · | -58.9 | · | · | · | -21.5 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -21.4 | · | · | |
| Earnings Yield | -3.7% | -4.2% | · | -8.7% | -15.8% | -14.4% | · | -20.3% | -67.8% | -83.8% | · | -245.1% | -246.9% | -139.9% | · | -43.8% |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $2M | $6M | $3M | — | — |
| 营业利润率 % | -8739.3% | -1633.7% | — | — | — |
| 净收入 | $-162M | $-85M | $-44M | $-28M | $-71M |
| 稀释后每股收益 (EPS) | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 13.3 | 15.2 | 18.4 | — | 16.6 |
| 速动比率 | 13.2 | 15.0 | 18.1 | — | 16.3 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | — | — | — | — | $-61M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。
机构持有人 (13F) 283 家申报者 · $4.7B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 66 (-38 与上一季度对比) | 31 (+14 与上一季度对比) | 111 (+32 与上一季度对比) | 69 (+12 与上一季度对比) | +3.9M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| FMR LLC | $572883234 | 5876931 | 12.24% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $264170313 | 2709995 | 5.64% | 股份 |
| Fairmount Funds Management LLC | $247325379 | 2537191 | 5.28% | 股份 |
| STATE STREET CORP | $229798634 | 2357440 | 4.91% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $210514689 | 2159568 | 4.50% | 股份 |
| Avidity Partners Management LP | $205115856 | 2104184 | 4.38% | 股份 |
| Octagon Capital Advisors LP | $179525699 | 1841667 | 3.83% | 股份 |
| TCG Crossover Management, LLC | $163437308 | 1676624 | 3.49% | 股份 |
| FRED ALGER MANAGEMENT, LLC | $126967018 | 1302493 | 2.71% | 股份 |
| Venrock Adviser, LLC | $115026400 | 1180000 | 2.46% | 股份 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $109695511 | 1125313 | 2.34% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $107328005 | 1100843 | 2.29% | 股份 |
| Polar Capital Holdings Plc | $99305410 | 1018726 | 2.12% | 股份 |
| CITADEL ADVISORS LLC | $95034324 | 974911 | 2.03% | 股份 |
| JENNISON ASSOCIATES LLC | $83073817 | 852214 | 1.77% | 股份 |
| BAKER BROS. ADVISORS LP | $83068947 | 852164 | 1.77% | 股份 |
| Logos Global Management LP | $77984000 | 800000 | 1.67% | 股份 |
| VANGUARD GROUP INC | $75241465 | 1825806 | 1.61% | 股份 |
| Cormorant Asset Management, LP | $73110000 | 750000 | 1.56% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $70001868 | 834150 | 1.50% | 股份 |
| BRAIDWELL LP | $57957904 | 594562 | 1.24% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $55574810 | 570115 | 1.19% | 股份 |
| AMERIPRISE FINANCIAL INC | $49641680 | 509247 | 1.06% | 股份 |
| Woodline Partners LP | $48793419 | 500548 | 1.04% | 股份 |
| MPM BIOIMPACT LLC | $40941795 | 420002 | 0.87% | 股份 |
| Affinity Asset Advisors, LLC | $38992000 | 400000 | 0.83% | 股份 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $38017200 | 390000 | 0.81% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $35674073 | 365963 | 0.76% | 股份 |
| Bain Capital Life Sciences Investors, LLC | $35333576 | 362470 | 0.75% | 股份 |
| Spruce Street Capital LP | $34587464 | 354816 | 0.74% | 股份 |
| Vivo Capital, LLC | $34507725 | 353998 | 0.74% | 股份 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $30697817 | 314914 | 0.66% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $29702156 | 304700 | 0.63% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $29485945 | 302482 | 0.63% | 股份 |
| Driehaus Capital Management LLC | $28782530 | 295266 | 0.61% | 股份 |
| First Turn Management, LLC | $27856957 | 285771 | 0.59% | 股份 |
| Assenagon Asset Management S.A. | $27357665 | 280649 | 0.58% | 股份 |
| TANG CAPITAL MANAGEMENT LLC | $25802176 | 264692 | 0.55% | 股份 |
| Artisan Partners Limited Partnership | $25176062 | 258269 | 0.54% | 股份 |
| RTW INVESTMENTS, LP | $24181181 | 248063 | 0.52% | 股份 |
| EMERALD ADVISERS, LLC | $24156031 | 247805 | 0.52% | 股份 |
| Pictet Asset Management Holding SA | $24106317 | 247295 | 0.51% | 股份 |
| TD Asset Management Inc | $21965558 | 225334 | 0.47% | 股份 |
| EVENTIDE ASSET MANAGEMENT, LLC | $21958442 | 225261 | 0.47% | 股份 |
| Candriam S.C.A. | $19887628 | 204214 | 0.42% | 股份 |
| STEMPOINT CAPITAL LP | $19578955 | 200851 | 0.42% | 股份 |
| Qube Research & Technologies Ltd | $19196152 | 196924 | 0.41% | 股份 |
| BANK OF AMERICA CORP /DE/ | $19072742 | 195658 | 0.41% | 股份 |
| Nicholas Investment Partners, LP | $18206242 | 186769 | 0.39% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $18033800 | 185000 | 0.39% | 股份 |
| GOLDMAN SACHS GROUP INC | $17941974 | 184058 | 0.38% | 股份 |
| Ensign Peak Advisors, Inc | $16979749 | 174187 | 0.36% | 股份 |
| Artia Global Partners LP | $15888265 | 162990 | 0.34% | 股份 |
| Balyasny Asset Management L.P. | $15792247 | 162005 | 0.34% | 股份 |
| Alyeska Investment Group, L.P. | $14679708 | 150592 | 0.31% | 股份 |
| Eagle Health Investments LP | $12803413 | 131344 | 0.27% | 股份 |
| EMERALD MUTUAL FUND ADVISERS TRUST | $12771635 | 131018 | 0.27% | 股份 |
| PFM Health Sciences, LP | $11816721 | 121222 | 0.25% | 股份 |
| Tri Locum Partners LP | $11767006 | 120712 | 0.25% | 股份 |
| ORBIMED ADVISORS LLC | $11210200 | 115000 | 0.24% | 股份 |
| Patient Square Capital LP | $10527840 | 108000 | 0.22% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $10474713 | 107455 | 0.22% | 股份 |
| NEUBERGER BERMAN GROUP LLC | $10217951 | 104821 | 0.22% | 股份 |
| Caption Management, LLC | $10128172 | 103900 | 0.22% | 买入期权 |
| SEVEN GRAND MANAGERS, LLC | $9748000 | 100000 | 0.21% | 股份 |
| Iron Triangle Partners LP | $9508383 | 230730 | 0.20% | 股份 |
| Atika Capital Management LLC | $9417738 | 96612 | 0.20% | 股份 |
| FIRST TRUST ADVISORS LP | $9177936 | 94152 | 0.20% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9133876 | 93700 | 0.20% | 买入期权 |
| BlackRock, Inc. | $9082017 | 93168 | 0.19% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $8952368 | 91838 | 0.19% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $8608947 | 88315 | 0.18% | 股份 |
| Russell Investments Group, Ltd. | $8608137 | 88306 | 0.18% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $8564593 | 87860 | 0.18% | 股份 |
| Rhenman & Partners Asset Management AB | $8395660 | 86127 | 0.18% | 股份 |
| Caption Management, LLC | $7505960 | 77000 | 0.16% | 卖出期权 |
| SAMLYN CAPITAL, LLC | $7304859 | 74937 | 0.16% | 股份 |
| Moody Aldrich Partners LLC | $7267329 | 74552 | 0.16% | 股份 |
| Swiss National Bank | $7194024 | 73800 | 0.15% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7116040 | 73000 | 0.15% | 卖出期权 |
| MERCER GLOBAL ADVISORS INC /ADV | $6402779 | 65683 | 0.14% | 股份 |
| LPL Financial LLC | $6365029 | 65295 | 0.14% | 股份 |
| SummitTX Capital, L.P. | $6225658 | 63866 | 0.13% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $6124571 | 62829 | 0.13% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $5853479 | 60048 | 0.13% | 股份 |
| Sio Capital Management, LLC | $5776080 | 59254 | 0.12% | 股份 |
| RHUMBLINE ADVISERS | $5704614 | 58521 | 0.12% | 股份 |
| Jones Hill Capital LP | $5566108 | 57100 | 0.12% | 股份 |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | $5560454 | 57042 | 0.12% | 股份 |
| ALPS ADVISORS INC | $5388792 | 55281 | 0.12% | 股份 |
| CITIGROUP INC | $5274935 | 54113 | 0.11% | 股份 |
| HighVista Strategies LLC | $4983665 | 51125 | 0.11% | 股份 |
| Burkehill Global Management, LP | $4874000 | 50000 | 0.10% | 股份 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $4738406 | 48609 | 0.10% | 股份 |
| JANE STREET GROUP, LLC | $4484080 | 46000 | 0.10% | 买入期权 |
| Seven Fleet Capital Management LP | $4257147 | 43672 | 0.09% | 股份 |
| CITADEL ADVISORS LLC | $4230632 | 43400 | 0.09% | 卖出期权 |
| Schonfeld Strategic Advisors LLC | $4223027 | 43322 | 0.09% | 股份 |
| D. E. Shaw & Co., Inc. | $4184621 | 42928 | 0.09% | 股份 |
| JANE STREET GROUP, LLC | $3986932 | 40900 | 0.09% | 卖出期权 |
公司内部人士 36 位内幕人士 · 10 位高管 · 14 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Ryan Savitz | EVP, CFO & CBO | 2026年7月9日 M | 0 | 0 | 4 | $-3857151 |
| Simrat Randhawa | EVP, Head of R&D | 2026年6月1日 M | 4000 | 0 | 3 | $-2404077 |
| David Wayne Nichols | Chief Technical Officer | 2022年8月1日 A | 14306 | 0 | 0 | $0 |
| Lisa Olson | Title: Head of Research and Chief Scientific Officer Exhibit 24.1: Power of Attorney | 2022年8月1日 A | 14264 | 0 | 0 | $0 |
| Jeffrey Humphrey | Chief Medical Officer | 2022年8月1日 A | — | 0 | 0 | $0 |
| John C. Davis JR | Title: Head of Research and Development and Chief Medical Officer | 2021年2月11日 A | 8304 | 0 | 0 | $0 |
| Zoran Zdraveski | Title: Secretary and Chief Legal and Technology Operations Officer | 2021年2月11日 A | 140092 | 0 | 0 | $0 |
| Christina K. Isacson | Chief Business Officer | 2020年2月10日 A | 103531 | 0 | 0 | $0 |
| Jason Ryan | Title: Chief Operating and Financial Officer | 2020年2月10日 A | — | 0 | 0 | $0 |
| COOKE MICHAEL P. | Chief Scientific Officer | 2019年2月5日 A | 293023 | 0 | 0 | $0 |
| Jonathan Violin | 董事 | 2025年5月22日 A | — | 0 | 0 | $0 |
| Paula Soteropoulos | 董事 | 2025年5月22日 A | — | 0 | 0 | $0 |
| Steven J. Romano | 董事 | 2025年5月22日 A | — | 0 | 0 | $0 |
| Alison Frances Lawton | 董事 | 2025年5月22日 A | — | 0 | 0 | $0 |
| MOULDER LEON O JR | 董事 | 2024年5月23日 A | 1436745 | 0 | 0 | $0 |
| Michael Vasconcelles | 董事 | 2022年8月15日 A | — | 0 | 0 | $0 |
| David Scadden | 董事 | 2022年6月28日 A | 228175 | 0 | 0 | $0 |
| Jeffrey W. Albers | 董事 | 2022年6月28日 A | 4152 | 0 | 0 | $0 |
| Thomas O Daniel | 董事 | 2022年6月28日 A | 101926 | 0 | 0 | $0 |
| Bruce Booth | 董事 | 2022年6月28日 A | 1250000 | 0 | 0 | $0 |
| Amy L Ronneberg | 董事 | 2022年6月28日 A | 593611 | 0 | 0 | $0 |
| Alexis Borisy | 董事 | 2021年8月26日 J | 4100 | 0 | 0 | $0 |
| Michael W Bonney | 董事 | 2021年6月1日 A | 215346 | 0 | 0 | $0 |
| Blake Byers | 董事 | 2020年6月5日 A | 3339137 | 0 | 0 | $0 |
| Atlas Venture Fund X, L.P. | 10% 所有者 | 2021年2月11日 J | 3148399 | 0 | 0 | $0 |
| Adam M Veness | — | 2026年8月13日 M | 15000 | 0 | 5 | $-4632790 |
| Anne Mcgeorge | — | 2026年8月10日 M | 0 | 0 | 5 | $-844822 |
| Simon Read | — | 2026年8月10日 M | 0 | 0 | 6 | $-304232 |
| Marino Garcia | — | 2026年8月7日 M | 65292 | 0 | 7 | $-17945450 |
| Sujay Kango | — | 2026年5月21日 A | — | 0 | 0 | $0 |
| Edward Carr | — | 2026年3月12日 M | 0 | 0 | 5 | $-3559495 |
| Caren Deardorf | — | 2022年11月30日 A | 19762 | 0 | 0 | $0 |
| Kristen Stants | — | 2022年11月30日 A | 20264 | 0 | 0 | $0 |
| Stephen F. Mahoney | — | 2022年11月30日 A | 17264 | 0 | 0 | $0 |
| Thomas W. Beetham | — | 2022年11月30日 A | 19897 | 0 | 0 | $0 |
| Jason Gardner | — | 2022年11月30日 A | 292872 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
激进投资者及 5%+ 股东 4 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Evan Harwin, Tomas Kiselak ×5 申报 | 2025年11月25日 | 4.90% | 修订 | — | SEC |
| Avidity Partners Management LP, Avidity Partners Management (GP) LLC, Avidity Capital Partners Fund (GP) LP, Avidity Capital Partners (GP) LLC, Avidity Private Master Fund I LP, Michael Gregory ×4 申报 | 2025年11月19日 | 4.90% | 修订 | 被动投资 | SEC |
| Viridian, LLC ×2 申报 | 2024年9月12日 | — | 初始申报 | — | SEC |
| ATLAS VENTURE FUND X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC ×4 申报 | 2023年9月15日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 49 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 3.09% | 34884 NS | 2026年5月31日 | N-PORT |
| SBIO · ALPS ETF Trust | 2.64% | 45839 NS | 2026年5月31日 | N-PORT |
| BBC · ETFis Series Trust I | 1.54% | 6551 NS | 2026年4月30日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.57% | 33605 NS | 2026年4月30日 | N-PORT |
| FYC · First Trust Exchange-Traded Alpha... | 0.47% | 55660 NS | 2026年4月30日 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.26% | 76617 NS | 2026年5月31日 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund ... | 0.20% | 1151 NS | 2026年5月31日 | N-PORT |
| FYX · First Trust Exchange-Traded Alpha... | 0.18% | 24819 NS | 2026年4月30日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.17% | 14250 NS | 2026年4月30日 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0.15% | 22043 NS | 2026年4月30日 | N-PORT |
| RSSL · Global X Funds | 0.10% | 15526 NS | 2026年4月30日 | N-PORT |
| FAD · First Trust Exchange-Traded Alpha... | 0.09% | 5190 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.08% | 1687 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.07% | 177996 NS | 2026年5月31日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.06% | 66 NS | 2026年5月31日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.05% | 5283 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.05% | 16047 NS | 2026年4月30日 | N-PORT |
| UWM · ProShares Trust | 0.05% | 1320 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.04% | 71218 NS | 2026年4月30日 | N-PORT |
| URTY · ProShares Trust | 0.04% | 1340 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 34 NS | 2026年5月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 3958 NS | 2026年4月30日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 869 NS | 2026年5月31日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 11461 NS | 2026年5月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.01% | 7297 NS | 2026年4月30日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 27975 NS | 2026年4月30日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 21529 NS | 2026年5月31日 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 770 NS | 2026年4月30日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 4404 NS | 2026年4月30日 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 1591 NS | 2026年5月31日 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.00% | 31 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 2026年7月30日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| ITOT · iShares Trust | — | — | 2026年7月22日 | 每日 |
| IWV · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWO · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWM · iShares Trust | — | — | 2026年8月18日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026年7月23日 | 每日 |
| VHT · VANGUARD WORLD FUND | — | — | 2026年7月20日 | 每日 |
| ISCB · iShares Trust | — | — | 2026年7月21日 | 每日 |
| ISCV · iShares Trust | — | — | 2026年7月20日 | 每日 |
| SMMV · iShares Trust | — | — | 2026年8月18日 | 每日 |
| ESML · iShares Trust | — | — | 2026年8月14日 | 每日 |
| IBRN · iShares Trust | — | — | 2026年8月6日 | 每日 |
| WSML · iShares Trust | — | — | 2026年7月20日 | 每日 |